Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
ConditionPostural Tachycardia Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University
About this trial
This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.
Eligibility criteria
Qualifiers
Adult patients (>18 years of age) diagnosed with POTS
Ability to provide informed consent
Ability to comply with 3 follow up visits
English speaking and capable of signing informed consent and complying with protocol requirements
Disqualifiers
Allergy to local anesthetics
Severe coagulopathy
History of or currently being treated for clinically significant ongoing cardiac arrhythmia, heart failure, myocarditis, pulmonary embolism requiring anticoagulation, pulmonary fibrosis or other pulmonary diagnosis that in the investigator's opinion may contribute to symptoms of POTS
Inability to maintain a stable medication regiment for the duration of the study
Trial design
Treatments tested in this trial
- Stellate ganglion block
- Sham injection of saline
- Ropivacaine
- Normal saline
Treatment groups
20 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov